Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 ...

Solvonis Therapeutics PLC (LSE:SVNS) chief scientific officer Professor David Nutt talked with Proactive's Stephen Gunnion about promising new data from preclinical trials of its lead molecule, ...

British neuropsychopharmacologist professor David Nutt is in Australia advocating for the use of regulatory-approved and evidence-based psychedelic-assisted therapies along with the nonprofit Mind ...

Alcohol is the most dangerous drug and is far more toxic and addictive than laughing gas, the government's former chief drug adviser has said. Professor David Nutt was sacked as the government's drug ...

Prof. Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines Professor David Nutt ...

CEO Anthony Tennyson talked with Proactive about the company’s decision to select SVN-114 as the lead candidate in its ...

Psychedelic drugs have long been exiled to the fringes of medicine, dismissed as recreational drugs with limited therapeutic potential. That all changed with the breakthrough therapy status granted ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

Professor David NuttDavid Nutt is professor of neuropsychopharmacology at Imperial College, London and founder of Drug Science UK. He was formerly the UK government’s chair of the Advisory Council on ...

The Atlanta Braves have done a lot this offseason — have they done enough to bounce back in 2026? Vikings QB Max Brosmer expected to start Week 17 with J.J. McCarthy sidelined due to fractured hand ...